| Literature DB >> 17458656 |
Zahid Hussain Khan1, Alireza Ebrahim Soltani, Payman Rahmani.
Abstract
We report the successful use of recombinant activated factor VII (rFVIIa) infusion in an 18-year-old man who underwent L3 laminectomy and pedicular screw fixation with severe refractory bleeding secondary to severe coagulopathy, which had remained unresponsive to conventional medical and surgical therapies. However, the patient developed a thromboembolic complication presumably associated with the use of rFVIIa. Although rFVIIa provides a dramatic response in intractable bleeding, it may cause a thromboembolic phenomenon which should be vigilantly considered and promptly treated.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17458656 DOI: 10.1007/s00540-006-0481-y
Source DB: PubMed Journal: J Anesth ISSN: 0913-8668 Impact factor: 2.078